Inovalon to Present at the Massachusetts Institute of Technology Future of Health Analytics Conference 2015

CEO to Present How Advanced Data-Driven Analytics & Technology Deliver Impact Across the Healthcare Landscape


BOWIE, Md., Feb. 23, 2015 (GLOBE NEWSWIRE) -- Inovalon (Nasdaq:INOV), a leading technology company providing advanced cloud-based analytics and data-driven intervention platforms to the healthcare industry, will present at the Massachusetts Institute of Technology (MIT) Future of Health Analytics Conference 2015 taking place Tuesday, February 24, 2015 at the MIT Media Lab in Cambridge, Massachusetts.

Keith Dunleavy, M.D., chief executive officer of Inovalon, will deliver a keynote speech addressing trends driving transformation within the industry, the rising role of data-driven analytics in solving healthcare's challenges, and how innovative technologies will be increasingly important in driving efficiency, clinical and quality impact and financial performance across the healthcare landscape.

About Inovalon

Inovalon is a leading technology company that combines advanced cloud-based data analytics and data-driven intervention platforms to achieve meaningful impact in clinical and quality outcomes, utilization, and financial performance across the healthcare landscape. Inovalon's unique achievement of value is delivered through the effective progression of Turning Data into Insight, and Insight into Action®. Large proprietary datasets, advanced integration technologies, sophisticated predictive analytics, and deep subject matter expertise deliver a seamless, end-to-end platform of technology and nationwide operations that bring the benefits of big data and large-scale analytics to the point of care. Driven by data, Inovalon uniquely identifies gaps in care, quality, data integrity, and financial performance–while bringing to bear the unique capabilities to resolve them. Supporting hundreds of healthcare organizations in 98.2% of U.S. counties and Puerto Rico, Inovalon's analytical and data-driven intervention platforms are informed by data pertaining to more than 754,000 physicians, 248,000 clinical facilities, and more than 120 million Americans providing a powerful solution suite that drives high-value impact, improving quality and economics for health plans, Accountable Care Organizations (ACOs), hospitals, physicians, patients and researchers. For more information, visit: www.inovalon.com.



            

Contact Data